epirubicin has been researched along with Dysplastic Nevus Syndrome, Hereditary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Deng, Y; Guo, T; Liu, X; Meng, X; Song, Y; Sui, D; Wang, M; Xu, Z; Zhang, K | 1 |
| Góralczyk, A; Wróblewska-Łuczka, P; Łuszczki, JJ | 1 |
2 other study(ies) available for epirubicin and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.
Topics: Breast Neoplasms; Cell Line, Tumor; Cholesterol; Epirubicin; Female; Humans; Immunotherapy; Ligands; Liposomes; Melanoma, Cutaneous Malignant; N-Acetylneuraminic Acid; Sialic Acid Binding Ig-like Lectin 1; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs.
Topics: Cisplatin; Coumarins; Cytostatic Agents; Docetaxel; Epirubicin; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mitoxantrone; Vemurafenib | 2023 |